Stephen Smolinski - 03 Jan 2022 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Signature
/s/ Christopher R. Sullivan, Attorney-in-Fact
Issuer symbol
AVTX
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 15:16:05 UTC
Next filing
06 Jan 2022

No securities are beneficially owned.